Cosmo Life Saving Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1612.67%
- Profit Growth 80.14%
- Ebitda 126.10%
- Net Worth -4.33%
- Total Assets 7.52%
About Cosmo Life Saving Drugs
Cosmo Life Saving Drugs Private Limited (CLSDPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 August 2021 (Three years and five months 12 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Gupta and Sneh Gupta serve as directors at the Company.
Company Details
- Location
Panchkula, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24299HR2021PTC097127
- Company No.
097127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Cosmo Life Saving Drugs Private Limited offer?
Cosmo Life Saving Drugs Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Dietary Supplements, Osteoporosis Medications, Vitamin Tablets & Capsules, Mineral Supplement, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Cosmo Life Saving Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Gupta  | Director | 20-Aug-2021 | Current |
| Sneh Gupta | Director | 20-Aug-2021 | Current |
Financial Performance of Cosmo Life Saving Drugs.
Cosmo Life Saving Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1612.67% increase. The company also saw a substantial improvement in profitability, with a 80.14% increase in profit. The company's net worth dipped by a decrease of 4.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmo Life Saving Drugs?
Unlock access to Cosmo Life Saving Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cosmo Life Saving Drugs?
Cosmo Life Saving Drugs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmo Life Saving Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmo Life Saving Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.